Neopenda Risk Report

🛡️ Financial & Liquidity

Neopenda has shown activity in financial and liquidity movements recently, particularly in securing new funding to support its operations and growth. The company has successfully engaged in convertible note financing and other financial activities to bolster its capital position.

• Chicago medtech startup Neopenda announced a new round of convertible note financing on 🗓 April 15, 2021.
• Neopenda raised USD 1 million from investors such as Axel Johnson Inc and Sunu Capital on 🗓 April 12, 2019.
• They completed a seed round to produce wearable neonatal monitors on 🗓 May 1, 2019.

📜 Innovation & R&D

Innovation is a core element of Neopenda's strategy, focusing on developing advanced medical devices to address critical needs in healthcare. They have been notably active in introducing innovative solutions, particularly concerning monitoring vital signs and adapting technology to combat COVID-19.

• Neopenda developed an adult version of its baby vitals monitor to help combat COVID, reported on 🗓 May 18, 2020.
• The company has been recognized for its wearable technology for reducing infant mortality, as noted on 🗓 March 13, 2018.
• Neopenda's innovative wearable neonatal monitors were highlighted on 🗓 May 1, 2019.